Adaptive designs for clinical trials with highly successful treatments

被引:13
作者
Ivanova, A
Rosenberger, WF
机构
[1] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[2] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA
来源
DRUG INFORMATION JOURNAL | 2001年 / 35卷 / 04期
关键词
ethics; measures of association; optimal allocation; power; urn models;
D O I
10.1177/009286150103500406
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We compare the performance of two adaptive designs and equal allocation in a clinical trial with two highly successful treatments and binary outcomes. The measure of interest in the trial is the odds ratio. The goal of the adaptive design is to decrease the total number of failures compared to equal allocation while keeping the power at the same level. One design is based on sequential maximum likelihood estimation, the other on an urn model. We find that the urn model produces a better procedure than the sequential maximum likelihood approach and equal allocation, in that it yields fewer expected treatment failures, maintains the power of the asymptotic test, and is more powerful when the Fisher's exact test is used. We conclude that adaptive designs have attractive properties when both treatments are highly successful.
引用
收藏
页码:1087 / 1093
页数:7
相关论文
共 11 条
[1]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[2]  
Flournoy N., 2000, Sankhya B, V62, P104
[3]  
FRIEDMAN LM, 1981, FUNDAMENTALS CLIN TR, P41
[4]  
Ivanova A, 2000, J Biopharm Stat, V10, P93, DOI 10.1081/BIP-100101016
[5]  
JENNISON C, 2000, GROUP SEQUENTIAL MET, P329
[6]  
Melfi V., NEW DEV APPL EXPT DE, P106
[7]  
Rosenberger W F, 1997, J Biopharm Stat, V7, P617, DOI 10.1080/10543409708835211
[8]   Optimal adaptive designs for binary response trials [J].
Rosenberger, WF ;
Stallard, N ;
Ivanova, A ;
Harper, CN ;
Ricks, ML .
BIOMETRICS, 2001, 57 (03) :909-913
[9]   Randomized play-the-winner clinical trials: Review and recommendations [J].
Rosenberger, WF .
CONTROLLED CLINICAL TRIALS, 1999, 20 (04) :328-342
[10]   Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: The COMPASS equivalence trial [J].
Tebbe, U ;
Michels, R ;
Adgey, J ;
Boland, J ;
Caspi, A ;
Charbonnier, B ;
Windeler, J ;
Barth, H ;
Groves, R ;
Hopkins, GR ;
Fennell, W ;
Betriu, A ;
Ruda, M ;
Mlczoch, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (03) :487-493